The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The mutant selection window and antimicrobial resistance
Abstract
The mutant selection window is an antimicrobial concentration range extending from the minimal concentration required to block the growth of wild-type bacteria up to that required to inhibit the growth of the least susceptible, single-step mutant. The upper boundary is also called the mutant prevention concentration (MPC). Placing antimicrobial concentrations inside the window is expected to enrich resistant mutant subpopulations selectively, whereas placing concentrations above the window is expected to restrict selective enrichment. Since window dimensions are characteristic of each pathogen-antimicrobial combination, they can be linked with antimicrobial pharmacokinetics to rank compounds and dosing regimens in terms of their propensity to enrich mutant fractions of bacterial populations. For situations in which antimicrobial concentrations cannot be kept above the window, restricting the enrichment of mutants requires combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Self-citationFox, W., Ellard, G. A., & Mitchison, D. A. (1999) · PubMed · Cited by 797
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H., & Schentag, J. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.521 · Cited by 507
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Wimberley, N., Faling, L. J., & Bartlett, J. G. (1979) · PubMed · doi:10.1164/arrd.1979.119.3.337 · Cited by 407
Zhao, X., & Drlica, K. (2001) · Clinical Infectious Diseases · doi:10.1086/321841 · Cited by 397
Self-citationCraig, W. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321854 · Cited by 318
Fagon, J.-Y., Chastre, J., Trouillet, J.-L., Domart, Y., Dombret, M.-C., Bornet, M., & Gibert, C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1004 · Cited by 314
Blondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
Self-citationDong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Self-citationNg, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Ho, P. L., Tse, W. S., Tsang, K. W. T., Kwok, T. K., Ng, T. K., Cheng, V. C. C., & Chan, R. M. T. (2001) · Clinical Infectious Diseases · doi:10.1086/319222 · Cited by 216
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
Firsov, A. A., Vostrov, S. N., Lubenko, I. Y., Drlica, K., Portnoy, Y. A., & Zinner, S. H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1604-1613.2003 · Cited by 215
Self-citationDNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Self-citationConcentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis
Feldman, W. E. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80003-0 · Cited by 212
Zhao, X., & Drlica, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338571 · Cited by 210
Self-citationJones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., Köhrer, K., & Schmitz, F.-J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.462-466.2000 · Cited by 158
Zhou, J., Dong, Y., Zhao, X., Lee, S., Amin, A. G., Ramaswamy, S. V., Domagala, J. M., Musser, J. M., & Drlica, K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315708 · Cited by 148
Self-citationDong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
Self-citationBast, D. J., Low, D. E., Duncan, C. L., Kilburn, L., Mandell, L. A., Davidson, R., & de Azavedo, J. C. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3049-3054.2000 · Cited by 122
A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae
Weiss, K., Restieri, C., Gauthier, R., Laverdière, M., McGeer, A., Davidson, R., Kilburn, L., Bast, D. J., de Azavedo, J., & Low, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/322658 · Cited by 116
Fluoroquinolone‐ResistantStreptococcus pneumoniaeAssociated with Levofloxacin Therapy
Urban, C. M., Rahman, N. A., Zhao, X., Mariano, N., Segal‐Maurer, S., Drlica, K., & Rahal, J. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/323086 · Cited by 110
Self-citationBacterial counts in cerebrospinal fluid of children with meningitis
Bingen, É., Lambert-zechovsky, N., Mariani‐Kurkdjian, P., Doit, C., Aujard, Y., Fournerie, F., & Mathieu, H. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01968060 · Cited by 109
Schentag, J. J. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.6.426 · Cited by 103
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Kays, M. B., Smith, D. W., Wack, M. F., & Denys, G. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.395.33185 · Cited by 93
Evolution of drug-resistant tuberculosis: a tale of two species.
Iseman, M. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2428 · Cited by 73
Join‐Lambert, O., Michea-Hamzehpour, M., Köhler, T., Chau, F., Faurisson, F., Dautrey, S., Vissuzaine, C., Carbon, C., & Pechère, J. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.571-576.2001 · Cited by 58
Zhao, X., Eisner, W., Perl-Rosenthal, N., Kreiswirth, B. N., & Drlica, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1023-1027.2003 · Cited by 49
Self-citationSchmitz, F., Fluit, A. C., Brisse, S., Verhoef, J., Köhrer, K., & Milatović, D. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01400.x · Cited by 48
Clinical Pharmacokinetics of Continuous Intravenous Administration of Penicillins
Visser, L. G., Arnouts, P., van Furth, R., Mattie, H., & van den Broek, P. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.491 · Cited by 40
Resistance to Quinolones in Gram-Negative Microorganisms: Mechanisms and Prevention
Baquero, F. (1990) · European Urology · doi:10.1159/000464084 · Cited by 40
Fogarty, C. M., Greenberg, R. N., Dunbar, L. M., Player, R., Marrie, T. J., Kojak, C., Morgan, N., & Williams, R. R. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80047-3 · Cited by 33
Streptococcus pneumoniae,Brooklyn, New York: Fluoroquinolone Resistance at our Doorstep
Quale, J. M., Landman, D., Ravishankar, J., Flores, C., & Bratu, S. (2002) · Emerging infectious diseases · doi:10.3201/eid0806.010275 · Cited by 33
Healy, D. P., Dansereau, R. J., Dunn, A. B., Clendening, C. E., Mounts, A. W., & Deepe, G. S. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101203 · Cited by 21
Cited by
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Metadata
- Authors
- Drlica, K.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-12
- Volume
- 52
- Issue
- 1
- Pages
- 11-17
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2149166791
- Cited by
- 437
- References
- 41
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.